Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The company claimed it contained the same active ingredient (semaglutide) found in Wegovy and Ozempic
Lose Weight & Gain Health Benefits of Semaglutide Effective Blood Sugar Control: Helps maintain stable blood sugar levels, reducing the risk of diabetes-related complications
Tirzepatide (Mounjaro/Zepbound) Timeline Phase 3 trials began: 2019 (SURPASS program for diabetes) FDA approval (Mounjaro for diabetes): May 2022 Commercial availability: June 2022, initial supply constraints Zepbound (obesity indication) Phase 3: 2020-2022 (SURMOUNT program) Zepbound FDA approval: November 2023 Zepbound commercial launch: December 2023, immediate shortages Stable widespread availability: Still not fully stable as of early 2026
The core formula is total peptide mass (mg) required concentration (mg/mL) = bacteriostatic water volume (mL)
US$ 28.70
US$ 21.81
US$ 22.17
US$ 21.38
US$ 29.40
